Fluconazole

Fluconazole is indicated for the treatment of the following conditions in adults:
– cryptococcal meningitis;
– coccidioidomycosis;
– invasive candidiasis;
– mucosal candidiasis, including oropharyngeal candidiasis, esophageal candidiasis, candiduria and chronic mucocutaneous candidiasis;
– chronic atrophic oral candidiasis (associated with wearing dentures), when oral hygiene or topical treatment are insufficient;
– vaginal candidiasis, acute or recurrent, when topical therapy is not applicable;
– candidal balanitis, when topical therapy is not applicable;
– dermatophytosis of the nails (onychomycosis), when treatment with other drugs is not acceptable;
– dermatomycoses, incl. athlete’s foot, athlete’s foot, inguinal tinea, lichen versicolor, and cutaneous candidiasis when systemic treatment is indicated.
Fluconazole is indicated for the prophylaxis of the following infections in adults:
– relapse of cryptococcal meningitis in patients at high risk of relapse;
– relapse of oropharyngeal and esophageal candidiasis in HIV-infected patients at high risk of relapse;
– to reduce the frequency of relapse of vaginal candidiasis (4 or more episodes per year);
– for the prophylaxis of candidal infections in patients with long-standing neuropenia (such as patients with hematological malignancies undergoing chemotherapy or patients undergoing hematopoietic stem cell transplantation).
Fluconazole is indicated for the treatment of children.
Fluconazole is used to treat mucosal candidiasis (oropharyngeal and esophageal candidiasis), invasive candidiasis, cryptococcal meningitis, and prophylaxis of candidal infections in immunocompromised patients. Fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children at high risk of relapse.

1 capsule of 150 mg